肺癌的现实数据和证据:对最近发展的回顾
Eleni Kokkotou1, Maximilian Anagnostakis1, Georgios Evangelou1
1Oncology Unit, Third Department of Medicine, "Sotiria" General Hospital for Chest Diseases, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Cancers
|April 13, 2024
概括
现实世界数据 (RWD) 研究为癌症治疗提供了有效的,现实世界的洞察力,解决了传统临床试验的局限性. 这些研究提高了对不同患者群体治疗有效性和安全性的理解.
科学领域:
- 在瘤学瘤学.
- 临床研究方法论 临床研究方法论
- 医疗信息学 医疗信息学
背景情况:
- 传统的癌症临床试验面临着时间,成本,患者参与和现实世界的应用性方面的挑战.
- 在护理点收集的真实世界数据 (RWD) 为弥补证据差距提供了解决方案.
- 与传统试验相比,RWD研究可以提高效率和平衡内部/外部有效性.
研究的目的:
- 突出现实世界数据 (RWD) 在癌症研究中的好处和应用.
- 探索RWD在药物监督和外部控制组组建中的潜力.
- 讨论实用性临床试验 (PCT) 的可行性,使用前性收集的RWD.
主要方法:
- 使用类似于传统临床试验的实验设计,用于RWD生成.
- 采用可审计的数据抽象方法和在护理地点采集电子数据.
- 利用前性收集的RWD进行实用临床试验 (PCT).
主要成果:
- RWD研究可以在现实环境中提供有关癌症治疗效果的重要信息.
- RWD促进了对疾病进展的理解,并支持药物监测.
- 使用RWD的PCT可以产生支持随机研究设计的证据,并将研究扩展到临床实践.
结论:
- 现实世界数据 (RWD) 和实用临床试验 (PCT) 对于推进癌症研究和治疗理解至关重要.
- 通过可审计的方法和电子捕获来确保数据质量对于RWD研究至关重要.
- 需要对新型药物的实际有效性,安全性和成本效益进行进一步的研究,特别是在代表性不足的人群中.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Statistical Methods for Analyzing Epidemiological Data
1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


